Invitation for participation
The European Society of Pathology (ESP) Foundation is continuing the successful organisation of External Quality Assurance (EQA) Programmes.
For 2022 we are proud to announce three separate EQA Schemes:
– The Colorectal Carcinomas (CRC) EQA Scheme includes KRAS, NRAS and BRAF testing. For more information please see the attaced CRC flyer. Registrations are open until 1 February 2022 and are available HERE.
– The Programmed Death Ligand 1 (PDL1) EQA Scheme includes testing in triple negative breast carcinoma (TNBC), non-small cell lung carcinoma (NSCLC), urothelial carcinoma (UC) and head and neck squamous cell cercinoma (HNSCC). For more information please see the attached PDL1 flyer. Registrations are open until 1 March 2022 and are available HERE.
– The ESP Lung 2022 EQA Scheme, the registrations for which will start soon. For information about the provided subschemes and instructions on how to register please see the attached Lung flyer.
European Society of Pathology